Nam Lab Publications


Zhang Z, Zhang W, Blakes R, Sundby LJ, Shi Z, Rockey DC, Ervasti JM, Nam YJ. Fibroblast fate determination during cardiac reprogramming by remodeling of actin filaments. Stem cell reports. 2022 Dec 12; 1604-1619. PMID: 35688153 [PubMed]PMC9287671


Zhang Z, Villalpando J, Zhang W, Nam YJ. Chamber-Specific Protein Expression during Direct Cardiac Reprogramming. Cells. 2021 Dec 16; PMID: 34208439 [PubMed]PMC8234528


Zhang Z, Nam YJ. Assessing Cardiac Reprogramming using High Content Imaging Analysis. Journal of visualized experiments : JoVE. 2020 Dec 26; PMID: 33165328 [PubMed]PMC7988430 NIHMSID: NIHMS1679187.


Cadar AG, Feaster TK, Bersell KR, Wang L, Hong T, Balsamo JA, Zhang Z, Chun YW, Nam YJ, Gotthardt M, Knollmann BC, Roden DM, Lim CC, Hong CC. Real-time visualization of titin dynamics reveals extensive reversible photobleaching in human induced pluripotent stem cell-derived cardiomyocytes. American journal of physiology. Cell physiology. 2019 Nov 20. PMID: 31747312 [PubMed]


Sutcliffe MD, Tan PM, Fernandez-Perez A, Nam YJ, Munshi NV, Saucerman JJ. High content analysis identifies unique morphological features of reprogrammed cardiomyocytes. Scientific reports. 2018 Dec 19; 1258 p. PMID: 29352247 [PubMed]PMC5775342


Nam YJ, Munshi NV. The Promise of Cardiac Regeneration by In Situ Lineage Conversion. Circulation. 2017 Mar 7; 914-916. PMID: 28264888 [PubMed]PMC5410767 NIHMSID: NIHMS847635.

Earlier Publications

Nam YJ, Mani K, Ashton AW, Peng CF, Krishnamurthy B, Hayakawa Y, Lee P, Korsmeyer SJ, Kitsis RN. Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Molecular cell. 2004 Sep 24; 901-12. PMID: 15383280 [PubMed]